Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Gracell Biotechnologies (Shanghai) Co., Ltd.
M.D. Anderson Cancer Center
Emory University
Alexion Pharmaceuticals, Inc.
Attralus, Inc.
Nanjing University School of Medicine
University of Tennessee Graduate School of Medicine
Eastern Cooperative Oncology Group
Barbara Ann Karmanos Cancer Institute
Attralus, Inc.
Oncopeptides AB
Tufts Medical Center
Takeda
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline
Alliance for Clinical Trials in Oncology
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Tennessee
University of Tennessee
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Tennessee
Northwestern University
Northwestern University
Mayo Clinic
NYU Langone Health
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Arizona
Rutgers, The State University of New Jersey